Well-Differentiated Neuroendocrine Tumor of the Bladder with SATB2 Expression: The First Reported Case Challenging Primary Bladder Origin in Favor of Metastatic Lower Gastrointestinal Disease

2026 ASCP/CAP-ACP Annual Meeting · 19 November 2026 · 12:30–13:15 · 517ABC - Exhibit Hall

Well-Differentiated Neuroendocrine Tumor of the Bladder with SATB2 Expression: The First Reported Case Challenging Primary Bladder Origin in Favor of Metastatic Lower Gastrointestinal Disease was a session at 2026 ASCP/CAP-ACP Annual Meeting on 19 November 2026 in Montreal, with 1 speaker on record.

Speakers

• Nathaniel Snyder1 — Speaker Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA 02111